Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIO-902 in Type 2 Diabetes
NCT00494663Phase 2Terminated
- Sponsor
- DiObex, Inc.
- Start
- Jul 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of levoketoconazole in type 2 diabetes mellitus (T2DM), sponsored by DiObex, Inc.. Started Jul 2007; status: terminated.
02
Drugs
levoketoconazole
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00494663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00494663.